Muhammad Umair Mushtaq, MD
Hematology & Oncology · Westwood, KSNPI 1245646397
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Sanofi at 51.1% of the total. 2025 is the largest year on record at $12,262, 4.5 times the $2,747 reported in 2022.
Across 32 payments — averaging $646.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$11K
- National Marrow Donor Program$7K
- Johnson & Johnson$2K
- Genentech USA, Inc.$2K
- Beigene USA, Inc.$70
- AbbVie$34
Across 30 payments — averaging $19,604 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Iovance Biotherapeutics, Inc.$498K
- Incyte Corporation$37K
- National Marrow Donor Program$34K
- Genentech, Inc.$20K
What the payments were for
- Consulting fees$9,25145%
- Speaking & faculty fees$1,8569%
- Travel & lodging$7,76538%
- Food & beverage$1,8259%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $10,579 |
| National Marrow Donor Program | 18 | $6,573 |
| Johnson & Johnson | 2 | $1,856 |
| Genentech USA, Inc. | 5 | $1,586 |
| Beigene USA, Inc. | 1 | $70 |
| AbbVie | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,697 in reported general payments places this provider in the 70th percentile of 97 hematology & oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 20 | $3,632 |
| Menveo A-C-Y-W-135-DipMening Vac A,c,y,w-135 Dip/Pf | 24 | $3,632 |
| PentacelDipht,pert(A),tet-Polio/Hib/Pf | 33 | $3,415 |
| Acyclovir | 86 | $980 |
| Hydrocortisone | 33 | $835 |
| Entecavir | 11 | $659 |
| Dapsone | 12 | $470 |
| Duloxetine Hcl | 25 | $426 |
| Rosuvastatin Calcium | 24 | $425 |
| Carvedilol | 36 | $334 |
| Prochlorperazine Maleate | 17 | $275 |
| Gabapentin | 11 | $241 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $142 |
| Pantoprazole Sodium | 12 | $138 |
| Oxycodone Hcl | 19 | $131 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Westwood
- Priyanka SharmaWestwood$135K
- Gary DoolittleWestwood$102K
- Sunil AbhyankarWestwood$78K
- Leyla ShuneWestwood$56K
- Anthony SungWestwood$49K
- Anup Kumar Kasi Loknath KumarWestwood$31K
- Prakash NeupaneWestwood$26K
- Jesus Gonzalez LugoWestwood$4K
- Qamar KhanWestwood$1K
- Tahani AtiehWestwood$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.